Alps Advisors Inc Immuno Gen, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$3.67 - $4.92 $2,811 - $3,768	-766 Reduced 0.51%	148,874 $571,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $132,732 - $184,075	29,172 Added 24.22%	149,640 $742,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $46,376 - $66,977	-10,352 Reduced 7.91%	120,468 $576,000
Q2 2022 Aug 11, 2022	SELL	$3.15 - $5.76 $301,861 - $551,975	-95,829 Reduced 42.28%	130,820 $589,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $89,928 - $157,902	-21,110 Reduced 8.52%	226,649 $1.08 Million
Q4 2021 Feb 09, 2022	SELL	$4.75 - $7.5 $33,169 - $52,372	-6,983 Reduced 2.74%	247,759 $1.84 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $43,247 - $56,772	-8,615 Reduced 3.27%	254,742 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$5.79 - $8.6 $1.52 Million - $2.26 Million	263,357 New	263,357 $1.74 Million
Q4 2020 Feb 03, 2021	SELL	$3.7 - $7.66 $823,575 - $1.71 Million	-222,588 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$3.45 - $4.89 $52,860 - $74,924	-15,322 Reduced 6.44%	222,588 $801,000
Q2 2020 Aug 05, 2020	SELL	$3.32 - $5.34 $250,669 - $403,186	-75,503 Reduced 24.09%	237,910 $1.09 Million
Q1 2020 May 06, 2020	BUY	$2.12 - $6.8 $20,193 - $64,770	9,525 Added 3.13%	313,413 $1.07 Million
Q4 2019 Feb 07, 2020	BUY	$2.25 - $5.8 $11,265 - $29,040	5,007 Added 1.68%	303,888 $1.55 Million
Q3 2019 Nov 04, 2019	SELL	$2.22 - $3.39 $31,326 - $47,836	-14,111 Reduced 4.51%	298,881 $723,000
Q2 2019 Aug 07, 2019	SELL	$1.8 - $3.3 $84,814 - $155,492	-47,119 Reduced 13.08%	312,992 $679,000
Q1 2019 May 01, 2019	BUY	$2.41 - $5.91 $37,475 - $91,900	15,550 Added 4.51%	360,111 $976,000
Q4 2018 Feb 04, 2019	BUY	$3.94 - $9.7 $318,549 - $784,245	80,850 Added 30.66%	344,561 $1.65 Million
Q3 2018 Oct 25, 2018	BUY	$8.6 - $11.26 $607,504 - $795,406	70,640 Added 36.59%	263,711 $2.5 Million
Q2 2018 Aug 02, 2018	BUY	$9.52 - $12.15 $442,889 - $565,242	46,522 Added 31.75%	193,071 $1.88 Million
Q2 2018 Jul 25, 2018	SELL	$9.52 - $12.15 $293,492 - $374,572	-30,829 Reduced 17.38%	146,549 $939,000
Q1 2018 May 01, 2018	BUY	$6.7 - $12.95 $206,554 - $399,235	30,829 Added 21.04%	177,378 $1.87 Million
Q4 2017 Feb 05, 2018	BUY	$5.07 - $7.92 $743,003 - $1.16 Million	146,549	146,549 $939,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account